Arabic Arabic English English French French German German
dark

Public Meeting on Patient Focused Drug Development for Narcolepsy Part 1

On September 24, 2013, FDA hosted a public meeting on Patient-Focused Drug Development for Narcolepsy. FDA was interested in obtaining patient perspectives on the impact of Narcolepsy on daily life and patient views on treatment approaches. For more information, visit https://go.usa.gov/x6Q3V

Read More

Total
0
Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

Public Meeting on Patient Focused Drug Development for Narcolepsy Part 2

Next Post

Tiziana Responds to UK Call for Development of Innovative ‘Take Home’ Treatments for COVID-19 Disease

Related Posts
Total
0
Share